GRAM publications
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Ikuta KS. et al, (2022), The Lancet
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis.
Browne AJ. et al, (2020), BMC Med, 18
Measuring and mapping the global burden of antimicrobial resistance.
Hay SI. et al, (2018), BMC Med, 16
Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.
Dolecek C. et al, (2022), PLoS Biol, 20
Recent publications by Researchers affiliated with the GRAM project
BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection
Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 100561 - 100561
Stakeholder's perspectives on acceptable interventions for promoting hypertension medication adherence in Namibia: nominal group technique.
Nakwafila O. et al, (2023), BMJ Open, 13
Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa.
Bwire G. et al, (2023), BMC Med, 21
Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus.
Du DH. et al, (2023), Trop Med Health, 51
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Siegel SV. et al, (2023), medRxiv
Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus.
Varghese GM. et al, (2023), N Engl J Med, 388, 792 - 803
Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Schilling WHK. et al, (2023), eLife, 12
Characteristics and One Year Outcomes of Melioidosis Patients in Northeastern Thailand: A Prospective, Multicenter Cohort Study.
Chantratita N. et al, (2023), Lancet Reg Health Southeast Asia, 9
Pre- and post-intervention survey on lung cancer awareness among adults in selected communities in KwaZulu-Natal, South Africa: A quasi-experimental study.
Dlamini SB. et al, (2023), J Public Health Afr, 14
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples
Abdel Hamid MM. et al, (2023), Wellcome Open Research, 8, 22 - 22
Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.
MalariaGEN None. et al, (2023), Wellcome open research, 8
Cost, health impacts and cost effectiveness of iceless refrigeration in India's last-mile vaccine cold chain delivery.
Plewes K. et al, (2022), Trans R Soc Trop Med Hyg
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
Watson JA. et al, (2022), eLife, 11
Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis.
Wasakul V. et al, (2022), Lancet Infect Dis
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.
Taylor WR. et al, (2022), Lancet Infect Dis